MCK MCKESSON CORP

P/E 19.69
Forward P/E 17.06
Price/Sales 0.219
Beta 0.315
Div Yield 0.0042%
Market Cap --

Company Analysis

Latest News

McKesson Announces Retirement of Chief Strategy Officer and Appoints Successor

McKesson Announces Retirement of Chief Strategy Officer and Appoints Successor

McKesson Corporation announced the upcoming retirement of its Executive Vice President, Chief Strategy and Business Development Officer, Thomas L. Rodgers. To...

🟢 MCK is trading 5.4% up today, rebounding from recent weakness

MCK is trading at $784.99 (5.4% up) in pre-market, rebounding from recent multi-day weakness despite broader index futures trading lower. • No fresh...

McKesson Subsidiary Enters into $2.25 Billion Senior Secured Term Loan Facility

McKesson Subsidiary Enters into $2.25 Billion Senior Secured Term Loan Facility

McKesson Corporation (MCK) disclosed that its subsidiary, McKesson Medical-Surgical Top Holdings, Inc., has entered into an amendment to its existing credit...

McKesson closes $1.25B Apollo deal, paving way for medical unit spinoff

McKesson closes $1.25B Apollo deal, paving way for medical unit spinoff

McKesson Corporation completed its transaction with Apollo Funds on June 1, 2026. Apollo invested $1.25 billion for a minority stake in the Medical-Surgical...

McKesson Medical Unit Prices $2.25 Billion Loan, Targeting Standalone IPO

McKesson Medical Unit Prices $2.25 Billion Loan, Targeting Standalone IPO

McKesson Corporation’s Medical-Surgical Solutions (MMS) unit priced a $2.25 billion leveraged loan on June 3, 2026. The financing establishes an independent...

McKesson Gains $1.65 Billion Stake From Norway’s Sovereign Wealth Fund

McKesson Gains $1.65 Billion Stake From Norway’s Sovereign Wealth Fund

Norges Bank established a new position in McKesson Corporation according to recent 13F regulatory filings. The sovereign wealth fund purchased 2,012,870...

McKesson Corporation Q1 2026 Earnings Preview: What Analysts Expect on May 13, 2026

For the reporting period ending March 31, 2026, analysts expect McKesson to post consensus revenue of $101.40 billion and an adjusted EPS of $11.56, while the...

McKesson's fourth quarter fiscal 2026 EPS of $11.69 beat estimates, driven by strong growth in its Oncology segment.

McKesson's fourth quarter fiscal 2026 EPS of $11.69 beat estimates, driven by strong growth in its Oncology segment.

McKesson reported fourth quarter fiscal 2026 revenues of $96.3 billion, a 6% increase year-over-year, with adjusted EPS growing 16% to $11.69. For the full...

McKesson Corporation Q1 2026 Earnings Preview: What Analysts Expect on May 07, 2026

McKesson is expected to report Q1 2026 revenue of $101.61 billion and EPS of $11.56, with the current stock price of $807.85 trading significantly below the...